Adjuvants: current status, clinical perspectives and future prospects.
about
Effect of adjuvants on immunization with dengue virus-induced cytotoxic factorTargeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditionsPoly-DL-lactide-co-glycolide microspheres as a controlled release antigen delivery system.Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune responseImproving vaccine performance with adjuvants.Outlining novel cellular adjuvant products for therapeutic vaccines against cancer.Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen.HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen.Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragmentVaccine adjuvants: current state and future trends.GM-CSF and IL-2 as adjuvant enhance the immune effect of protein vaccine against foot-and-mouth disease.Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity.Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in miceIntestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation.Survey of human-use adjuvants.Immunomodulatory properties of porins of some members of the family Enterobacteriaceae.Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12.Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.Adjuvant modulation of immune responses to tuberculosis subunit vaccines.Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720).General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines.Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future NeedsVaccine adjuvants - Current status and prospects on controlled release adjuvancity.Promising particle-based vaccines in cancer therapy.T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice.Carbohydrate-based vaccine adjuvants - discovery and development.An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.Immunologic adjuvants for modern vaccine formulations.Comparing Antibody Responses in Chickens Against Plasmodium falciparum Lactate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase with Freund's and Pheroid® Adjuvants.Augmentation of NKT and NK cell-mediated cytotoxicity by peptidoglycan monomer linked with zinc.Immunological requirements for a subunit vaccine against tuberculosis.Immunostimulating agents: what next? A review of their present and potential medical applications.Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease.Evaluation of immune response elicited by inulin as an adjuvant with filarial antigens in mice model.Characterization of Weissella ceti infections in Brazilian rainbow trout, Oncorhynchus mykiss (Walbaum), farms and development of an oil-adjuvanted vaccine.Bordetella bronchiseptica antigen enhances the production of Mycoplasma hyopneumoniae antigen-specific immunoglobulin G in mice.Expression of the Plasmodium berghei ookinete protein Pbs21 in a baculovirus-insect cell system produces an efficient transmission blocking immunogen.Lymphocyte proliferative response in brown bears: cytokine role and glucocorticoid effect.Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.
P2860
Q27473531-9928035D-5BDF-4B48-A65D-3C6BFF85F559Q28589559-40560E55-CBE4-494B-BC0D-B531265B57AEQ33646641-5ED0BDB0-EAB1-4AE0-9A52-9701BCC9F144Q33825265-4129A188-654C-4717-893B-DA2EDDB5D7FAQ33956247-0794F624-712D-4C46-A231-7397590B8386Q33997622-72F6E36F-DB7B-4D3D-9EA4-D0DAF8E7A2D5Q34002944-BF196FA2-D268-4C27-ADA4-2273C0582B84Q34111694-2ECA3088-A605-4B43-A6A0-CD0CA38EB6E1Q34238526-468ED287-C334-453B-AEBA-C5B1D8F0EB07Q34347904-31D8F8DD-2AE0-4252-94D9-EDB144DEC98AQ34358206-C1FF55D0-E120-41BF-90DE-8BE17164F64DQ34510446-CF0E890F-E9BE-47A7-8AA1-265BFA105D5CQ35003701-249732CC-FF65-44CC-B727-B9A1D7755BC9Q35091726-634D99FD-7437-4C2B-8D96-43DD381A0581Q35106621-60964CD7-9F7C-4496-844B-56DAB4793FCDQ35192171-53709287-1EF5-4856-AEA1-47469D927684Q35549669-D3A6813D-6B4B-479C-98C4-9E6BA282A6D5Q35556712-8962C5A2-B819-4038-AD30-71B385EBBAB3Q35557454-788259EA-8CAF-4FF7-AA52-3F9B71631CDCQ35567180-8E2FB336-15AE-4D7B-B3BB-904A4DA73709Q35833323-3E83CBB1-2B9E-4FEA-AB5F-A0FC9E9855F3Q35947735-FC6BD738-CB83-4E1D-ADE3-EC62D216048AQ36191001-F3B0B548-99D6-4EEB-9AA2-175F3FBB5C0DQ37098801-3A50E442-057D-4C59-9662-31209C3A2F51Q37259642-9CD067AE-E8EF-46F1-AE99-EE32E8C6DB98Q37366590-266C30BB-5536-4291-985D-0599EF1E25FCQ38587300-4AA41C33-6F66-47F5-8074-30F75267F56CQ39174792-E483E773-49BA-40F0-B340-3197E90BA368Q40454313-D2E5F63B-B048-4EF2-B196-A85CB8349491Q40466912-47ACC76A-B258-49E5-8BD6-5BAF526EA361Q40725795-3C87FC82-8256-4189-8C62-FEA812D91054Q40867776-94F68079-FF55-48D7-9514-661EC143EC2FQ40920163-09B239FE-4B22-477C-AEFA-CDD339B0D63CQ41754977-7A3EBF5F-E870-453B-8BC1-F9251A8B5FE8Q42205390-24EDE66F-F713-4F3E-940A-39EF499D0BE2Q42222593-CBD1DF43-D83C-42AA-843C-76D3D3E6C7AEQ42376184-99504C4E-A958-471B-9066-2C94488B43AEQ44168850-9B848D15-CEAA-4EB4-B597-EA69B5CE2203Q44210788-27CF43D9-69A8-446E-A9DC-4203B6EA4DA5Q44542837-20AC064C-D876-4BD7-92EE-BF24AF11E1C2
P2860
Adjuvants: current status, clinical perspectives and future prospects.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Adjuvants: current status, clinical perspectives and future prospects.
@en
type
label
Adjuvants: current status, clinical perspectives and future prospects.
@en
prefLabel
Adjuvants: current status, clinical perspectives and future prospects.
@en
P1433
P1476
Adjuvants: current status, clinical perspectives and future prospects.
@en
P2093
P304
P356
10.1016/0167-5699(93)90046-N
P577
1993-06-01T00:00:00Z